MELTEMI THERAPEUTICS

Serial Number 85032580
606

Registration Progress

Application Filed
May 7, 2010
Under Examination
Jul 5, 2011
Approved for Publication
Apr 20, 2011
Published for Opposition
May 10, 2011
Registered

Basic Information

Serial Number
85032580
Filing Date
May 7, 2010
Published for Opposition
May 10, 2011
Abandonment Date
August 11, 2014
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 11, 2014
Classes
005 042

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
3rd Floor
300 3rd Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Ann Lamport Hammitte

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

38 events
Date Code Type Description
Aug 11, 2014 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Aug 11, 2014 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jan 14, 2014 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Jan 13, 2014 EX5G S SOU EXTENSION 5 GRANTED
Jan 2, 2014 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 2, 2014 EXT5 S SOU EXTENSION 5 FILED
Jul 23, 2013 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Jul 22, 2013 EX4G S SOU EXTENSION 4 GRANTED
Jul 12, 2013 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 17, 2013 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 17, 2013 EXT4 S SOU EXTENSION 4 FILED
Jan 8, 2013 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Jan 7, 2013 EX3G S SOU EXTENSION 3 GRANTED
Jan 3, 2013 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 3, 2013 EXT3 S SOU EXTENSION 3 FILED
Jul 4, 2012 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Jul 3, 2012 EX2G S SOU EXTENSION 2 GRANTED
Jun 29, 2012 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 12, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 12, 2012 EXT2 S SOU EXTENSION 2 FILED
Jan 5, 2012 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Jan 3, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 3, 2012 EXT1 S SOU EXTENSION 1 FILED
Jan 3, 2012 EX1G S SOU EXTENSION 1 GRANTED
Jul 5, 2011 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
May 10, 2011 PUBO A PUBLISHED FOR OPPOSITION
Apr 20, 2011 NPUB O NOTICE OF PUBLICATION
Apr 6, 2011 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 29, 2011 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 15, 2011 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2011 ACEC I AMENDMENT FROM APPLICANT ENTERED
Mar 8, 2011 ALIE A ASSIGNED TO LIE
Feb 28, 2011 MAIL I PAPER RECEIVED
Aug 24, 2010 CNRT F NON-FINAL ACTION MAILED
Aug 23, 2010 CNRT R NON-FINAL ACTION WRITTEN
Aug 19, 2010 DOCK D ASSIGNED TO EXAMINER
May 13, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 11, 2010 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
a full line of pharmaceuticals, biosimilars and biological preparations for medical purposes
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
scientific research, scientific research in the fields of pharmaceuticals, biosimilars, biologics, and medicine
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"